CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Micrus Endovascular Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Micrus Endovascular Corporation
821 Fox Lane
Phone: (408) 433-1400p:408 433-1400 San Jose, CA  95131  United States Ticker: MENDMEND

This company was Merged or Acquired on 9/27/2010.
This company ceased filing statements with the SEC on 9/27/2010.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Micrus Endovascular Corporation develops, manufactures and markets implantable and disposable medical devices used in the treatment of cerebral vascular diseases. The Company’s products are used by interventional neuroradiologists, interventional neurologists and endovascularly trained neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Its product lines consist of endovascular systems that enable a physician to gain access to the brain in a minimally invasive manner through the vessels of the arterial system. The Company’s family of embolic coils anatomically conforms to a diversity of aneurysm shapes and sizes. It also supplies products, such as guide catheters, micro catheters, occlusion balloon catheters, guide wires and stents for the treatment of both hemorrhagic and ischemic stroke.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20103/31/2010YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chief Executive Officer, Principal Executive Officer John T.Kilcoyne 51 9/24/2007 12/1/2004
President, Chief Operating Officer, Secretary Robert A.Stern 53 11/12/2007 1/1/2004
Chief Financial Officer, Principal Financial Officer Gordon T.Sangster 57 11/12/2007 11/12/2007
10 additional Officers and Directors records available in full report.

Business Names
Business Name
MEND
Micrus Endovascular SA
Micrus Endovascular UK Ltd.

General Information
Number of Employees: 307 (As of 3/31/2010)
Outstanding Shares: 16,585,666 (As of 8/2/2010)
Shareholders: 52
Stock Exchange: NASD
Federal Tax Id: 232853441
Fax Number: (408) 433-1401


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023